Overexpression of c-erb B2 is a negative prognostic factor in anaplastic astrocytomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overexpression of c-erb B2 is a negative prognostic factor in anaplastic astrocytomas

Published:2010-03-23 Issue:1 Volume:5 Page:
ISSN:1746-1596
Container-title:Diagnostic Pathology
language:en
Short-container-title:Diagn Pathol

Author:

Gulati Sasha,Ytterhus Borgny,Granli Unn S,Gulati Michel,Lydersen Stian,Torp Sverre H

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/1746-1596-5-18.pdf

Reference62 articles.

1. Stupp R, Reni M, Gatta G, Mazza E, Vecht C: Anaplastic astrocytoma in adults. Crit Rev Oncol Hematol. 2007, 63: 72-80.

2. Chang SM, Parney IF, Huang W, Anderson FA, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER, Glioma Outcomes Project I: Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005, 293: 557-564.

3. Buckner JC: Factors influencing survival in high-grade gliomas. Semin Oncol. 2003, 30: 10-14.

4. Bazley LA, Gullick WJ: The epidermal growth factor receptor family. Endocr Relat Cancer. 2005, 12 (Suppl 1): S17-27.

5. Hamel W, Westphal M: Growth factors in gliomas revisited. Acta Neurochir (Wien). 2000, 142: 113-137. discussion 137-118

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human epidermal growth factor receptor 2 neu and E-cadherin expression in primary astrocytic brain tumors as prognostic biomarkers;Al-Azhar Assiut Medical Journal;2021-01

2. An immunohistochemical study of HER2 expression in primary brain tumors;BioMedicine;2020-03-28

3. Receptor Tyrosine Kinases: Principles and Functions in Glioma Invasion;Advances in Experimental Medicine and Biology;2020

4. Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model;Oncogene;2019-02-12

5. Prognostic value of ErbB2/HER2 in human meningiomas;PLOS ONE;2018-10-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3